BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26461462)

  • 1. Goodness-of-fit test of the stratified mark-specific proportional hazards model with continuous mark.
    Sun Y; Li M; Gilbert PB
    Comput Stat Data Anal; 2016 Jan; 93():348-358. PubMed ID: 26461462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mark-specific proportional hazards model with multivariate continuous marks and its application to HIV vaccine efficacy trials.
    Sun Y; Li M; Gilbert PB
    Biostatistics; 2013 Jan; 14(1):60-74. PubMed ID: 22764174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PROPORTIONAL HAZARDS MODELS WITH CONTINUOUS MARKS.
    Sun Y; Gilbert PB; McKeague IW
    Ann Stat; 2009 Feb; 37(1):394-426. PubMed ID: 19838313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothesis tests for stratified mark-specific proportional hazards models with missing covariates, with application to HIV vaccine efficacy trials.
    Sun Y; Qi L; Yang G; Gilbert PB
    Biom J; 2018 May; 60(3):516-536. PubMed ID: 29488249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mark-specific additive hazards regression with continuous marks.
    Han D; Sun L; Sun Y; Qi L
    Lifetime Data Anal; 2017 Jul; 23(3):467-494. PubMed ID: 27170333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mark-specific hazard ratio model with missing multivariate marks.
    Juraska M; Gilbert PB
    Lifetime Data Anal; 2016 Oct; 22(4):606-25. PubMed ID: 26511033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Goodness-of-fit test for monotone proportional subdistribution hazards assumptions based on weighted residuals.
    Boher JM; Filleron T; Giorgi R; Kramar A; Cook RJ
    Stat Med; 2017 Jan; 36(2):362-377. PubMed ID: 27790725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of Stratified Mark-Specific Proportional Hazards Models with Missing Marks.
    Sun Y; Gilbert PB
    Scand Stat Theory Appl; 2012 Mar; 39(1):34-52. PubMed ID: 23519918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inferences on relative failure rates in stratified mark-specific proportional hazards models with missing marks, with application to HIV vaccine efficacy trials.
    Gilbert PB; Sun Y
    J R Stat Soc Ser C Appl Stat; 2015 Jan; 64(1):49-73. PubMed ID: 25641990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mark-specific hazard ratio model with multivariate continuous marks: an application to vaccine efficacy.
    Juraska M; Gilbert PB
    Biometrics; 2013 Jun; 69(2):328-37. PubMed ID: 23421613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of Stratified Mark-Specific Proportional Hazards Models under Two-Phase Sampling with Application to HIV Vaccine Efficacy Trials.
    Yang G; Sun Y; Qi L; Gilbert PB
    Stat Biosci; 2017 Jun; 9(1):259-283. PubMed ID: 28781713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tests for comparing mark-specific hazards and cumulative incidence functions.
    Gilbert PB; McKeague IW; Sun Y
    Lifetime Data Anal; 2004 Mar; 10(1):5-28. PubMed ID: 15130048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 2-sample problem for failure rates depending on a continuous mark: an application to vaccine efficacy.
    Gilbert PB; McKeague IW; Sun Y
    Biostatistics; 2008 Apr; 9(2):263-76. PubMed ID: 17704528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mark-specific quantile regression model.
    Qu L; Sun L; Sun Y
    Biometrika; 2024 Mar; 111(1):255-272. PubMed ID: 38948429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Goftte: A R package for assessing goodness-of-fit in proportional (sub) distributions hazards regression models.
    Sfumato P; Filleron T; Giorgi R; Cook RJ; Boher JM
    Comput Methods Programs Biomed; 2019 Aug; 177():269-275. PubMed ID: 31319955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Goodness-of-fit test for proportional subdistribution hazards model.
    Zhou B; Fine J; Laird G
    Stat Med; 2013 Sep; 32(22):3804-11. PubMed ID: 23625840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Checking Fine and Gray subdistribution hazards model with cumulative sums of residuals.
    Li J; Scheike TH; Zhang MJ
    Lifetime Data Anal; 2015 Apr; 21(2):197-217. PubMed ID: 25421251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case-only method for cause-specific hazards models with application to assessing differential vaccine efficacy by viral and host genetics.
    Dai JY; Li SS; Gilbert PB
    Biostatistics; 2014 Jan; 15(1):196-203. PubMed ID: 23813283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable selection for a mark-specific additive hazards model using the adaptive LASSO.
    Han D; Qu L; Sun L; Sun Y
    Stat Methods Med Res; 2021 Sep; 30(9):2017-2031. PubMed ID: 34266342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Hybrid Approach for the Stratified Mark-Specific Proportional Hazards Model with Missing Covariates and Missing Marks, with Application to Vaccine Efficacy Trials.
    Sun Y; Qi L; Heng F; Gilbert PB
    J R Stat Soc Ser C Appl Stat; 2020 Aug; 69(4):791-814. PubMed ID: 33191955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.